Related references
Note: Only part of the references are listed.IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
Joshua Bennett et al.
CURRENT OPINION IN HEMATOLOGY (2022)
Lipid-induced monokine cyclophilin-A promotes adipose tissue dysfunction implementing insulin resistance and type 2 diabetes in zebrafish and mice models of obesity
Dipanjan Banerjee et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways
Milton Pereira et al.
CELL REPORTS (2022)
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
Rossella Sartorius et al.
NPJ VACCINES (2021)
Vanillin: a review on the therapeutic prospects of a popular flavouring molecule
Sagar S. Arya et al.
ADVANCES IN TRADITIONAL MEDICINE (2021)
MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling
Martin C. Moncrieffe et al.
STRUCTURE (2020)
Toll-like Receptors and the Control of Immunity
Katherine A. Fitzgerald et al.
CELL (2020)
Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis
Michael D. Wiese et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein Degradation
Jing Zhang et al.
CELL CHEMICAL BIOLOGY (2020)
Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors: an updated patent review (2016-2018)
William T. McElroy
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies
Molly A. Smith et al.
NATURE CELL BIOLOGY (2019)
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Kumar Vijay
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Mechanism of ubiquitin transfer promoted by TRAF6
Tian-Min Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Comparative efficacy of vanilloids in inhibiting toll-like receptor-4 (TLR-4)/myeloid differentiation factor (MD-2) homodimerisation
Chun-Wai Mai et al.
FOOD & FUNCTION (2018)
Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling
Dominic De Nardo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor
Karin Hjorton et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma
Daoxiang Zhang et al.
CLINICAL CANCER RESEARCH (2017)
IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes
Leah Cushing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Crystal structure of human IRAK1
Li Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Vanillin Affects Amyloid Aggregation and Non-Enzymatic Glycation in Human Insulin
Clara Iannuzzi et al.
SCIENTIFIC REPORTS (2017)
The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists
Stefan Vollmer et al.
BIOCHEMICAL JOURNAL (2017)
Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4
Mahesh Chandra Patra et al.
MOLECULES (2016)
Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use
Jing Sun et al.
SCIENCE SIGNALING (2016)
Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use
Jing Sun et al.
SCIENCE SIGNALING (2016)
Interleukin-1 receptor associated kinase inhibitors: Potential therapeutic agents for inflammatory- and immune-related disorders
Malkeet Singh Bahia et al.
CELLULAR SIGNALLING (2015)
Vanillin-Bioconversion and Bioengineering of the Most Popular Plant Flavor and Its De Novo Biosynthesis in the Vanilla Orchid
Nethaji J. Gallage et al.
MOLECULAR PLANT (2015)
Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain
Pragnesh Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
IRAK4 Dimerization and trans-Autophosphorylation Are Induced by Myddosome Assembly
Ryan Ferrao et al.
MOLECULAR CELL (2014)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Sensing of microbial molecular patterns by Toll-like receptors
Dong Hyun Song et al.
IMMUNOLOGICAL REVIEWS (2012)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells
Kyung W. Song et al.
MOLECULAR IMMUNOLOGY (2009)
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
Luke A. J. O'Neill et al.
PHARMACOLOGICAL REVIEWS (2009)
Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and Toll-like receptor-mediated NF-κB activation
Dietrich B. Conze et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Crystal structures of IRAK-4 kinase in complex with inhibitors: A serine/threonine kinase with tyrosine as a gatekeeper
Zhulun Wang et al.
STRUCTURE (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Cutting edge: Expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex
AE Medvedev et al.
JOURNAL OF IMMUNOLOGY (2005)
Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling
C Kollewe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction
AF McGettrick et al.
MOLECULAR IMMUNOLOGY (2004)
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway
M Yamamoto et al.
SCIENCE (2003)
Mechanisms of vanilloid-induced apoptosis
N Hail
APOPTOSIS (2003)
Pyogenic bacterial infections in humans with IRAK-4 deficiency
C Picard et al.
SCIENCE (2003)
Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members
S Janssens et al.
MOLECULAR CELL (2003)
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
N Suzuki et al.
NATURE (2002)
IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase
SY Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
